Patients with cancer
Conditions
Interventions
Manual Monitoring Group:NA
CHPS Monitoring Group:NA
Sponsors
Shenzhen Second People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age greater >18 years old; 2. Admissions to Shenzhen Second People's Hospital from September 1, 2022, to December 31, 2023; 3. Patients with cancer who have been diagnosed according to the guidelines and consensus of CSCO and NCCN; 4. Patients with cancer for whom albumin-bound paclitaxel is approved for use in foreign countries, or recommended by guidelines or consensus; 5. Have signed the informed consent for off-label use of albumin-bound paclitaxel; 6. Pathological staging: Stages I-IV.
Exclusion criteria
Exclusion criteria: 1. Patients with breast cancer or breast cancer with co-morbidities; 2. According to the drug instructions, the use of albumin-bound paclitaxel is prohibited.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ADR incidence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequencies of adverse reactions in blood, GI, and skin systems; | — |
Countries
China
Contacts
Public ContactShuke Long
Shenzhen Second People's Hospital
Outcome results
None listed